Protective effects of S-nitrosoglutathione against amyloid β-peptide neurotoxicity
Protective effects of S-nitrosoglutathione against amyloid β-peptide neurotoxicity
复制标题
DOI:
10.1016/j.freeradbiomed.2004.12.019
复制
发表时间:
2005-04-01
影响因子:
7.4
通讯作者:
Yang, DI
中科院分区:
文献类型:
--
作者:
Ju, TC;Chen, SD;Yang, DI
Amyloid beta-peptide (A beta) is a major constituent of senile plaques in the brains of Alzheimer's disease (AD) patients. We have previously demonstrated ceramide production secondary to A beta-induced activation of neutral sphingomyelinase (nSMase) in cerebral endothelial cells and oligodendrocytes, which may contribute to cellular injury during progression of AD. In this study, we first established the "A beta -> nSMase -> ceramide -> free radical -> cell death" pathway in primary cultures of fetal rat cortical neurons. We also provided experimental evidence showing that S-nitrosoglutathione (GSNO), a potent endogenous antioxidant derived from the interaction between nitric oxide (NO) and glutathione, caused dose-dependent protective effects against A beta/ceramide neurotoxicity via inhibition of caspase activation and production of reactive oxygen species (ROS). This GSNO-mediated neuroprotection appeared to involve activation of cGMP-dependent protein kinase (PKG), phosphatidylinositol 3-kinase (PI3K), and extracellular signal-regulated kinase (ER-K). Activation of the cGMP/PKG pathway induced expression of thioredoxin and Bcl-2 that were beneficial to cortical neurons in antagonizing A beta/ceramide toxicity. Consistently, exogenous application of thioredoxin exerted remarkable neuroprotective efficacy in our experimental paradigm. Results derived from the present study establish a neuroprotective role of GSNO, an endogenous NO carrier, against A beta toxicity via multiple signaling pathways. (c) 2004 Elsevier Inc. All rights reserved.